Notebook

Concerns over governance have nixed a merger between New York's Mount Sinai and New York University medical centers. The proposed venture, announced in June (M.E. Watanabe, The Scientist, Aug. 19, 1996, page 1), would have united the hospitals and medical schools of the two institutions. But according to a report in the February 15 New York Times (E.B. Fein, page 25), the deal fell through because Mount Sinai and NYU could not agree on who would control the combined medical school. Sources told

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Concerns over governance have nixed a merger between New York's Mount Sinai and New York University medical centers. The proposed venture, announced in June (M.E. Watanabe, The Scientist, Aug. 19, 1996, page 1), would have united the hospitals and medical schools of the two institutions. But according to a report in the February 15 New York Times (E.B. Fein, page 25), the deal fell through because Mount Sinai and NYU could not agree on who would control the combined medical school. Sources told the Times that Mount Sinai saw the school as "an independent entity involving equal partnership between the two sides," while NYU "wanted the medical school to be an integral part of its university, like its law school, film school, and other divisions." Neither John W. Rowe, Mount Sinai's president, nor NYU dean Saul Farber returned calls from The Scientist seeking comment. In a joint statement, the institutions ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies